Dec 12, 2023 8:30 am EST NightHawk Biosciences Announces Strategic Shift into a Pure-Play Large Molecule Biomanufacturing CDMO to Capitalize on Rapid Growth in Sales Pipeline along with Divestiture of Non-Core Assets
Oct 21, 2022 8:00 am EDT Nighthawk Biosciences’ Scorpion Subsidiary Announces Grand Opening of its San Antonio Facility
Aug 23, 2022 7:30 am EDT NightHawk Biosciences Announces Buildout of Advanced Biosafety Level 2 (BSL-2) Laboratory
Jun 13, 2022 8:00 am EDT NightHawk Biosciences Appoints Stephan Kutzer, Ph.D. as Interim Chief Executive Officer of Scorpion Biological Services